E-Mail : info@incozen.com


Reseach & Development

The past decade has witnessed tremendous growth in cancer research with significant advances made in molecular medicine and genomics. Following the initial success of targeted therapy, the treatment paradigm shifted to the use of a patient’s own defenses leading to the development of CAR T-cell and immunotherapy. Aided by nanotechnology and precision medicine, the concept of a ‘cancer free world’ appears to be a certain possibility in the next several years.

Incozen aims to become a cancer specialty company that can make a difference to patients across the globe through its drug discovery and development efforts in indications where there is a significant un-met medical need. The success of Incozen’s small molecule programs across therapeutic areas over the past decade areas lend credence to the team’s scientific expertise and decision-making capabilities and paves the way for the company’s future diversified growth and expansion in the oncology space.